| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 02/19/2008 | US7332498 N-(3-amino-propyl)-N-[1-(3-benzyl-4-oxo-3,4-dihydro-pyrido[2,3-d]pyrimidin-2-yl)-2-methyl-propyl]-4-methyl-benzamide; kinesin spindle protein inhibitor; cell division, mitosis phase arrest; antiproliferative and antiinflammation agent, hyperplasias, restenosis, cardiac hypertrophy, autoimmune disorders |
| 02/19/2008 | US7332497 Pyrazolopyrimidines as therapeutic agents |
| 02/19/2008 | US7332486 9-(4-carboxyphenyl)-6-cyclopropylamino-2-trifluoromethylpurine; side effect reduction; cognition activator, antidepressants, neuroleptic agent, schizophrenia, Alzheimer's disease, schizophrenia, Parkinson's, Huntington's, Pick's, Creutzfeld-Jakob, cardiovascular diseases, HIV |
| 02/19/2008 | US7332484 2,4-pyrimidinediamine compounds and their uses |
| 02/19/2008 | US7332483 3-(5-benzamido-2-chlorophenyl)-7-methoxy-3,4-dihydroquinazolin-4-one;cytokines (tumor necrosis factor and interleukins) inhibitor; antiinflammatory agent, rheumatoid arthritis, osteoarthritis, psoriasis, chronic obstructive pulmonary disease |
| 02/19/2008 | US7332301 Insulin-like growth factor binding protein |
| 02/19/2008 | US7332185 Component I selected from alpha acids and beta acids and component II selected from alpha acids, beta acids, essential oils, fats and waxes; specific inhibition of cyclooxygenase-2 with little effect on cyclooxygenase-1 |
| 02/19/2008 | US7332180 Transdermal therapeutic system for administering non-steroidal antiphlogistic agents containing carboxyl groups, and a method for the production of the same |
| 02/19/2008 | US7332163 Gamma-1 and gamma-3 anti-human CD23 monoclonal antibodies and use thereof as therapeutics |
| 02/19/2008 | US7331951 Devices and methodologies useful in body aesthetics |
| 02/19/2008 | CA2431565C Pharmaceutical compositions based on anticholinergics and ciclesonide |
| 02/19/2008 | CA2369726C Powder inhaler for combined medicament |
| 02/19/2008 | CA2328927C Benzamide derivatives for the treatment of diseases mediated by cytokines |
| 02/19/2008 | CA2316310C Gamma-glutamyl and beta-aspartyl containing immunomodulator compounds and methods therewith |
| 02/19/2008 | CA2277207C Use of dichlorobenzyl alcohol for preparing a preparation for topical treatment of inflammation and a preparation containing dichlorobenzyl alcohol |
| 02/19/2008 | CA2273240C Compositions and methods for treating or preventing inflammatory diseases |
| 02/19/2008 | CA2265893C Oily patches for external use containing diclofenac sodium |
| 02/19/2008 | CA2173976C Phenylacetate and derivatives alone or in combination with other compounds against neoplastic conditions and other disorders |
| 02/19/2008 | CA2132613C Method and compositions for enhancing white blood cell functioning on a mucosal or cutaneous surface |
| 02/14/2008 | WO2008019306A2 Aryl amino acid derivatives as inhibitors of lta4h (leukotriene a4 hydrolase) for treating inflammation |
| 02/14/2008 | WO2008019284A1 Phenoxymethylalkyne inhibitors of lta4h for treating inflammation |
| 02/14/2008 | WO2008018827A1 Benzimidazole derivatives useful in treatment of vallinoid receptor trpv1 related disorders |
| 02/14/2008 | WO2008018641A1 Monoclonal antibodies against stromal derived factor-1 (sdf-1) |
| 02/14/2008 | WO2008018517A1 Therapeutic and/or preventive agent for disease accompanied by cell overgrowth, and polynucleotide useful as the active ingredient |
| 02/14/2008 | WO2008018447A1 Aminoalcohol derivative and immunosuppressant containing the same as active ingredient |
| 02/14/2008 | WO2008018427A1 Aminophosphoric acid ester derivative and s1p receptor modulator containing the same as active ingredient |
| 02/14/2008 | WO2008017824A1 Bicyclo [2. 2. 1] hept-7-ylamine derivatives and their use |
| 02/14/2008 | WO2008017752A2 Eucalyptus extract, method of preparation and therapeutic uses thereof |
| 02/14/2008 | WO2008017691A1 Pyridine derivatives as sodium channel blockers |
| 02/14/2008 | WO2008017390A1 Compositions for the treatment of chronic degenerative inflammatory conditions |
| 02/14/2008 | WO2008017164A1 Thiophenecarboxamide derivatives as ep4 receptor ligands |
| 02/14/2008 | WO2007138072A3 Triazolopyrazine compounds useful for the treatment of degenerative & inflammatory diseases |
| 02/14/2008 | WO2007130780A3 Benzimidazole modulators of vr1 |
| 02/14/2008 | WO2007052173A3 Activity of thap-family chemokine-binding domains |
| 02/14/2008 | US20080039622 2,4-pyrimidinediamine compounds and their uses |
| 02/14/2008 | US20080039522 Composition Containing a Complex Comprising a Metal Ion and a Carboxylate Ligand Having Anti-Inflammatory Activity |
| 02/14/2008 | US20080039509 Histone Deacetylase Inhibitors or Novel Benzamine Derivatives with Potent Differentiation and Anti-Proliferation Activity |
| 02/14/2008 | US20080039499 Chemical Compounds |
| 02/14/2008 | US20080039494 8-Phenyl-5,6,7,8-Hydroquinoline Tachykinin Receptor Antagonists |
| 02/14/2008 | US20080039478 Bicycloheteroaryl Compounds as P2X7 Modulators and Uses Thereof |
| 02/14/2008 | US20080039474 Novel heterocyclic substituted pyridine compounds with cxcr3 antagonist activity |
| 02/14/2008 | US20080039473 Preparation and utility of substituted quinazoline compounds with alpha-adrenergic blocking effects |
| 02/14/2008 | US20080039465 Triazolyl phenyl benzenesulfonamides |
| 02/14/2008 | US20080039464 Compounds Which Modulate The CB2 Receptor |
| 02/14/2008 | US20080039457 Triazolotriazines as kinase inhibitors |
| 02/14/2008 | US20080039456 4-[2-(4-nitro-phenyl)-6-oxo-4-thioxo-6H-1-oxa-3b,5-diaza-cyclopenta[a]pentalen-5-yl]-butyric acid, used for inhibiting heparin-binding proteins and in the treatment of pancreatic cancer; anticarcinogenic agents |
| 02/14/2008 | US20080039455 Pyrazolopyrimidines and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same |
| 02/14/2008 | US20080039451 Use of thiazole derivatives for preparing a medicament intended to protect the mitochondria |
| 02/14/2008 | US20080039450 Compounds |
| 02/14/2008 | US20080039449 [1,4]benzodiazepine derivatives, used for treating osteoarthritis, pancreatitis, glomerulonephritis, rheumatoid arthritis, inflammatory bowel disease, Crohn's disease, psoriasis, graft vs host disease, leukemia, septic shock, multiple sclerosis, and inflammatory bowel disease |
| 02/14/2008 | US20080039444 Antiallergens; antiinflammatory agents; rhinitis |
| 02/14/2008 | US20080039433 Stabilized Tetracycline Compositions |
| 02/14/2008 | US20080039426 2-(4-fluoro-2-methylphenylamino)-1,6-dimethyl-7-[3-(4-methyl-4-oxo-4 lambda 5[1,4]azaphosphinan-1-yl)-propenyl]-1,8-dihydro-imidazo[4,5-h]isoquinolin-9-one; anticancer agents, antiinflammatory agents, antiviral agents, anti-thromboembolic agents, as well as for treating autoimmune disease |
| 02/14/2008 | US20080039422 Vitamin B12-Containing Compositions and Methods of Use |
| 02/14/2008 | US20080039419 Integrin-linked kinase and its uses |
| 02/14/2008 | US20080039376 Use of Cyclic Anabaenopeptin-type Peptides for the Treatment of a Condition Wherein Inhibition of Carboxypeptidase U is Beneficial, Novel Anabaenopeptin Derivatives and Intermediates Thereof |
| 02/14/2008 | US20080039364 Modulating serum amyloid a interaction with tanis and agents useful for same |
| 02/14/2008 | US20080038372 Artificial Physiological Salt Solution and Manufacturing Method for Same |
| 02/14/2008 | US20080038338 Tetracycline Package Formulations |
| 02/14/2008 | US20080038330 Preparations for the application of anti-inflammatory, especially antiseptic agents and/or agents promoting the healing of wounds of the lower respiratory tract |
| 02/14/2008 | US20080038309 Use of polypeptides obtained through systematic mutations of single amino acids of human and non-human Box-A of HMGB1 to prevent and/or antagonize pathologies induced by HMGB1 |
| 02/14/2008 | US20080038307 Biocompatible Coating, Method, and Use of Medical Surfaces |
| 02/14/2008 | US20080038283 Methods of Evaluating Efficacy of an Immune Response by Assesing Alpha-1 Integrin Expression |
| 02/14/2008 | US20080038273 Preventing CD28 binding to B7 by monovalent fragments antibody called CD28.3 of which exhibit sufficient affinity for the antigen so that they can be used, in vitro or in vivo, to block the CD28 receptor without activation of this receptor; autoimmune diseases; transplant rejection |
| 02/14/2008 | US20080038264 Compositions and methods for the treatment of immune related diseases |
| 02/14/2008 | US20080038242 sodium-dependent nucleoside transporter 2 inhibitors; for diseases associated with abnormal plasma uric acid levels such as gout, hyperuricemia, urinary lithiasis, hyperuriciemic nephropathy, and acute uric acid nephropathy |
| 02/14/2008 | US20080038234 Bone Marrow-Related Cells Associated With Tissue Maintenance And/Or Repair |
| 02/14/2008 | US20080038228 Method |
| 02/14/2008 | US20080038224 Modified interferon-beta (IFN-beta) polypeptides |
| 02/14/2008 | US20080038208 Pharmaceutical/cosmetic compositions comprising the lysine-d-proline-valine tripeptide |
| 02/14/2008 | US20080038199 Methods Related to the Treatment of Neurodegenerative and Inflammatory Conditions |
| 02/14/2008 | DE102006037495A1 Use of substances with pharmacological action e.g. xenon for producing a preparation, in which components of the preparation are a gas or a lightly volatile fluid, for administration of the substances to humans or animals over the eyes |
| 02/14/2008 | CA2660695A1 Compositions comprising extracts of salix and andrographis paniculata useful in the treatment of chronic inflammatory conditions |
| 02/14/2008 | CA2660133A1 Thiophenecarboxamide derivatives as ep4 receptor ligands |
| 02/14/2008 | CA2659599A1 Amino alcohol derivative and immunosuppressive agent having same as an active ingredient |
| 02/14/2008 | CA2659598A1 Amino phosphate derivative and s1p receptor modulator having same as an active ingredient |
| 02/14/2008 | CA2659162A1 Eucalyptus extract, method of preparation and therapeutic uses thereof |
| 02/13/2008 | EP1887016A1 Fragments of human chorionic gonadotropin (hcg) as immunoregulator |
| 02/13/2008 | EP1887008A1 Thienotriazolodiazepine compound and a medicinal use thereof |
| 02/13/2008 | EP1887005A1 Processes for production of optically active ppar-activating compounds and intermediates for production thereof |
| 02/13/2008 | EP1887003A1 3-[4-heterocyclyl -1,2,3-triazol-1-yl]-n-aryl-benzamides as inhibitors of the cytokines production for the treatment of chronic inflammatory diseases |
| 02/13/2008 | EP1887000A1 Arylacetate derivative having isoxazole skeleton |
| 02/13/2008 | EP1886993A1 Benzo[f]isoindole derivatives with affinity to the ep4 receptor |
| 02/13/2008 | EP1886712A1 Compositions for the treatment of chronic degenerative inflammatory conditions |
| 02/13/2008 | EP1886689A1 Oxidative stress inhibitor |
| 02/13/2008 | EP1885855A2 Cytokine receptor modulators and uses thereof |
| 02/13/2008 | EP1885722A1 Quinoline derivatives as ep4 antagonists |
| 02/13/2008 | EP1885704A2 Antagonists of the vanilloid receptor subtype 1 (vr1) and uses thereof |
| 02/13/2008 | EP1885365A2 Treatment of sepsis and inflammation with alpha2a adrenergic antagonists |
| 02/13/2008 | EP1885356A2 Phosphoinositide 3-kinase inhibitors for inhibiting leukocyte accumulation |
| 02/13/2008 | EP1885351A1 Methods and compositions for the treatment of pain |
| 02/13/2008 | EP1750735B1 Use of an extract of aloysia/verbrena/lippia triphylla/citridora for the preparation of a medicament for the treatment of chronic and/or inflammatory diseases |
| 02/13/2008 | EP1680421B1 Use of tricyclic compounds as glycine transport inhibitors |
| 02/13/2008 | EP1517679B1 Ortho-substituted benzoic acid derivatives for the treatment of insulin resistance |
| 02/13/2008 | EP1490025B1 Nanoparticulate compositions of map kinase inhibitors |
| 02/13/2008 | EP1480973B1 1,4-disubstituted benzofused cycloalkyl urea compounds useful in treating cytokine mediated diseases |
| 02/13/2008 | EP1476752A4 Method for diagnosing and monitoring hemostatic dysfunction, severe infection and systematic inflammatory response syndrome |
| 02/13/2008 | EP1470148A4 Double-stranded oligonucleotides |
| 02/13/2008 | EP1463716B1 Pyrrolidine and piperidine derivates as nk1 antagonists |
| 02/13/2008 | EP1404650B1 Carboxamide-substituted phenylurea derivatives and method for production thereof as medicaments |